EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combined Schisandrin B and Temozolomide Treatment Induces Mitochondrial Apoptosis in Glioma Cells

Zebo Tang, Chaoran Guo, Na Wen, Hong Jin, Yuan Dong, Bo Xu, Xiangyu Ma, Liu Han, Jianxin Liu

Frontiers in Bioscience-Landmark · 2025

DOI: 10.31083/fbl46410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Zebo Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neuroscience, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, 132013 Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Apoptosis, Lignans, Polycyclic Compounds, Temozolomide. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin province science and technology development plan, Foundation of Innovation and Entrepreneurship Program of college students in Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Temozolomide (TMZ) is a standard chemotherapeutic agent for glioma, but prolonged use frequently leads to drug resistance, reducing its therapeutic efficacy. Schisandrin B (Sch B), a lignan isolated from Schisandra chinensis, demonstrates promising anti-neoplastic activity. This study investigated the synergistic effects of Sch B and TMZ on U87 glioma cells to explore their combined influence on cell viability, apoptosis, and mitochondrial function.

Methods

U87 glioma cells were treated with Sch B, TMZ, or their combination. Cell viability was assessed using MTT assays. Apoptosis was evaluated by Hoechst staining and flow cytometry, while JC-1 staining and Western blotting were used to assess mitochondrial membrane potential, oxidative stress markers, and apoptosis-related proteins. Cell cycle analysis and pre-treatment with Z-VAD-FMK were performed to confirm pathway involvement.

Results

Combination treatment significantly reduced cell viability (54.14%) compared to TMZ (72.47%) or Sch B (70.4%) alone. Flow cytometry indicated elevated apoptosis (22.3%) in the combination group. JC-1 staining and protein expression analyses revealed mitochondrial depolarization, cytochrome c release, activation of caspase-3 and -9, and a decreased Bcl-2/Bax ratio. The combined treatment induced G2/M cell cycle arrest via p53/p21 activation and increased oxidative stress. Pre-treatment with Z-VAD-FMK partially reversed these effects, confirming caspase-dependent mitochondrial apoptosis.

Conclusions

Sch B enhances TMZ-induced cytotoxicity in U87 glioma cells by promoting mitochondrial dysfunction, oxidative stress, and caspase-mediated apoptosis. These findings suggest that Sch B may serve as a promising adjuvant to improve the efficacy of TMZ-based glioma therapy, warranting further validation in resistant and in-vivo models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisLignansPolycyclic CompoundsTemozolomideGliomaMitochondriaHumansCell Line, TumorCyclooctanesCell SurvivalMembrane Potential, MitochondrialOxidative StressDrug Synergism

Stichwörter der Autor:innen

Sch BTMZdrug resistanceglioblastomamitochondrial apoptosis

Substanzen

LignansPolycyclic CompoundsTemozolomideschizandrin BCyclooctanes

Autor:innen und Institutionen

  • Institute of Neuroscience, Translational Medicine Institute, Xi'an Jiaotong University Health Science Center, 132013 Xi'an, Shaanxi, China.
  • College of Basic Medical Sciences, Jilin Medical University, 132013 Jilin, Jilin, China.
  • College of Pharmacy, Jilin Medical University, 132013 Jilin, Jilin, China.

Förderung

  • Jilin province science and technology development plan
  • Foundation of Innovation and Entrepreneurship Program of college students in Jilin Province

Zitieren

APA

Tang, Z., Guo, C., Wen, N., Jin, H., Dong, Y., Xu, B., Ma, X., Han, L., & Liu, J. (2025). Combined Schisandrin B and Temozolomide Treatment Induces Mitochondrial Apoptosis in Glioma Cells. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl46410

Vancouver

Tang Z, Guo C, Wen N, Jin H, Dong Y, Xu B, et al. Combined Schisandrin B and Temozolomide Treatment Induces Mitochondrial Apoptosis in Glioma Cells. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl46410

BibTeX
@article{Tang2025,
  author = {Tang, Zebo and Guo, Chaoran and Wen, Na and Jin, Hong and Dong, Yuan and Xu, Bo and Ma, Xiangyu and Han, Liu and Liu, Jianxin},
  title = {Combined Schisandrin B and Temozolomide Treatment Induces Mitochondrial Apoptosis in Glioma Cells},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  doi = {10.31083/fbl46410}
}
Kostenlos starten →